FDA Import Refusal 1FX-0332117-1/10002/1 — Gkm Pharma
The FDA refused shipment 1FX-0332117-1/10002/1 from Gkm Pharma (India) on June 23, 2026. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75
Refusal Details
- Date
- June 23, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75